# Vericel Corp: filings

VCEL · Nasdaq · CIK 887359 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/vcel.md) · [Financials](/companies/vcel/financials.md) · [Filings](/companies/vcel/filings.md) · [Insiders](/companies/vcel/insiders.md)

## Reports and events: 341 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 437, 8-K 220, 144 113, SC 13G/A 56, 10-Q 53, 424B5 35, 3 25, 5 22, DEF 14A 21, SC 13G 20, UPLOAD 19, CT ORDER 18, 10-K 17, CORRESP 16, S-8 POS 15, EFFECT 14, 8-K/A 11, DEFA14A 11, S-8 11, 4/A 10, S-1/A 9, 424B3 7, 3/A 6, PRE 14A 6, S-3 6, SCHEDULE 13G/A 6, 10-Q/A 5, ARS 4, S-1 4, 144/A 3, POS AM 3, 8-A12B/A 2, S-3ASR 2, SCHEDULE 13G 2, SC TO-I/A 2, SEC STAFF LETTER 2, 10-K/A 1, 10-KT 1, 424B4 1, 8-A12B 1, D 1, DEL AM 1, FWP 1, NT 10-K 1, POS EX 1, S-3/A 1, S-3MEF 1, SC TO-C 1, SC TO-I 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 08:49 ET | [10-Q](/filings/0001628280-26-050836.md) | Quarterly report, period 2026-06-30 | 0001628280-26-050836 |
| 2026-07-30 | 08:03 ET | [8-K](/filings/0001628280-26-050815.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-050815 |
| 2026-05-18 | 16:05 ET | [8-K](/filings/0001140361-26-021892.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001140361-26-021892 |
| 2026-05-07 | 08:54 ET | [10-Q](/filings/0001628280-26-031742.md) | Quarterly report, period 2026-03-31 | 0001628280-26-031742 |
| 2026-05-07 | 07:57 ET | [8-K](/filings/0001628280-26-031713.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-031713 |
| 2026-05-01 | 16:05 ET | [8-K](/filings/0001140361-26-018538.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-26-018538 |
| 2026-03-19 | 07:30 ET | [DEF 14A](/filings/0001308179-26-000094.md) | Proxy statement, period 2026-04-29 | 0001308179-26-000094 |
| 2026-02-26 | 09:00 ET | [10-K](/filings/0001628280-26-012013.md) | Annual report, period 2025-12-31 | 0001628280-26-012013 |
| 2026-02-26 | 08:02 ET | [8-K](/filings/0001628280-26-012003.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-26-012003 |
| 2026-01-13 | 09:11 ET | [8-K](/filings/0001140361-26-001060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-001060 |
| 2025-11-06 | 08:47 ET | [10-Q](/filings/0001628280-25-049902.md) | Quarterly report, period 2025-09-30 | 0001628280-25-049902 |
| 2025-11-06 | 08:03 ET | [8-K](/filings/0001628280-25-049880.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-049880 |
| 2025-07-31 | 08:50 ET | [10-Q](/filings/0001628280-25-036859.md) | Quarterly report, period 2025-06-30 | 0001628280-25-036859 |
| 2025-07-31 | 08:14 ET | [8-K](/filings/0001628280-25-036854.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-036854 |
| 2025-05-08 | 08:53 ET | [10-Q](/filings/0001628280-25-023496.md) | Quarterly report, period 2025-03-31 | 0001628280-25-023496 |
| 2025-05-08 | 08:04 ET | [8-K](/filings/0001628280-25-023481.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-023481 |
| 2025-05-02 | 16:06 ET | [8-K](/filings/0001140361-25-017110.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-25-017110 |
| 2025-04-14 | 07:55 ET | [8-K](/filings/0001140361-25-013625.md) | 7.01 Regulation FD disclosure | 0001140361-25-013625 |
| 2025-03-20 | 07:30 ET | [DEF 14A](/filings/0001308179-25-000169.md) | Proxy statement, period 2025-04-30 | 0001308179-25-000169 |
| 2025-02-27 | 08:57 ET | [10-K](/filings/0001628280-25-008447.md) | Annual report, period 2024-12-31 | 0001628280-25-008447 |
| 2025-02-27 | 08:00 ET | [8-K](/filings/0001628280-25-008444.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-25-008444 |
| 2025-01-14 | 16:05 ET | [8-K](/filings/0001140361-25-001060.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-25-001060 |
| 2024-11-07 | 08:48 ET | [10-Q](/filings/0001628280-24-046015.md) | Quarterly report, period 2024-09-30 | 0001628280-24-046015 |
| 2024-11-07 | 08:01 ET | [8-K](/filings/0001628280-24-045997.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-045997 |
| 2024-08-26 | 08:03 ET | [8-K](/filings/0001140361-24-038472.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-038472 |
| 2024-08-15 | 16:08 ET | [8-K](/filings/0001140361-24-037511.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-24-037511 |
| 2024-08-01 | 09:05 ET | [10-Q](/filings/0001628280-24-033905.md) | Quarterly report, period 2024-06-30 | 0001628280-24-033905 |
| 2024-08-01 | 08:04 ET | [8-K](/filings/0001628280-24-033894.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-033894 |
| 2024-05-08 | 08:59 ET | [10-Q](/filings/0001628280-24-021399.md) | Quarterly report, period 2024-03-31 | 0001628280-24-021399 |
| 2024-05-08 | 08:10 ET | [8-K](/filings/0001628280-24-021382.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-021382 |
| 2024-05-03 | 16:05 ET | [8-K](/filings/0001140361-24-024327.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-24-024327 |
| 2024-03-21 | 07:30 ET | [DEF 14A](/filings/0001308179-24-000206.md) | Proxy statement, period 2024-05-01 | 0001308179-24-000206 |
| 2024-02-29 | 09:04 ET | [10-K](/filings/0001628280-24-007824.md) | Annual report, period 2023-12-31 | 0001628280-24-007824 |
| 2024-02-29 | 08:04 ET | [8-K](/filings/0001628280-24-007807.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-24-007807 |
| 2024-01-09 | 16:05 ET | [8-K](/filings/0001140361-24-001518.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-24-001518 |
| 2023-11-08 | 09:11 ET | [10-Q](/filings/0001628280-23-037583.md) | Quarterly report, period 2023-09-30 | 0001628280-23-037583 |
| 2023-11-08 | 08:06 ET | [8-K](/filings/0001628280-23-037567.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-037567 |
| 2023-09-20 | 16:31 ET | [8-K](/filings/0001104659-23-102314.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-102314 |
| 2023-08-02 | 08:47 ET | [10-Q](/filings/0001628280-23-026596.md) | Quarterly report, period 2023-06-30 | 0001628280-23-026596 |
| 2023-08-02 | 08:03 ET | [8-K](/filings/0001628280-23-026579.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-026579 |
| 2023-05-10 | 08:49 ET | [10-Q](/filings/0001628280-23-017039.md) | Quarterly report, period 2023-03-31 | 0001628280-23-017039 |
| 2023-05-10 | 08:03 ET | [8-K](/filings/0001628280-23-017028.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-017028 |
| 2023-05-05 | 16:06 ET | [8-K](/filings/0001140361-23-023201.md) | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001140361-23-023201 |
| 2023-03-23 | 08:00 ET | [DEF 14A](/filings/0001308179-23-000307.md) | Proxy statement | 0001308179-23-000307 |
| 2023-02-23 | 09:03 ET | [10-K](/filings/0001628280-23-004714.md) | Annual report, period 2022-12-31 | 0001628280-23-004714 |
| 2023-02-23 | 08:02 ET | [8-K](/filings/0001628280-23-004701.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-23-004701 |
| 2023-01-10 | 16:10 ET | [8-K](/filings/0001104659-23-002721.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-002721 |
| 2022-12-29 | 16:05 ET | [8-K](/filings/0001104659-22-130934.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-22-130934 |
| 2022-11-09 | 08:52 ET | [10-Q](/filings/0001628280-22-029082.md) | Quarterly report, period 2022-09-30 | 0001628280-22-029082 |
| 2022-11-09 | 08:04 ET | [8-K](/filings/0001628280-22-029065.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001628280-22-029065 |

Page 1 of 7. [Older](/companies/vcel/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 14:59 ET. No prices; not investment advice.